Zimmer Biomet Holdings (ZBH) EBT Growth (3y) (2012 - 2026)

Zimmer Biomet Holdings (ZBH) EBT Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Growth (3y) (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -2.47%
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 7.77%
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 0.70%
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 37.81%
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 4.82%
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn -2.57%
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 32.11%
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 61.06%
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 14.40%
10 Zimmer Biomet Holdings 17.27 Bn 16.86 Bn 1.51 Bn 1.66%

Historic Data

Download Data
DateValue
Mar 31, 2026 1.66%
Dec 31, 2025 10.40%
Sep 30, 2025 16.28%
Jun 30, 2025 4.03%
Mar 31, 2025 31.29%
Dec 31, 2024 2.15%
Sep 30, 2024 6.49%
Jun 30, 2024 19.27%
Mar 31, 2024 0.16%
Dec 31, 2023 -7.95%
Sep 30, 2023 -5.02%
Jun 30, 2023 48.09%
Mar 31, 2023 36.96%
Dec 31, 2022 -26.09%
Sep 30, 2022 -1.28%
Jun 30, 2022 12.45%
Mar 31, 2022 -29.73%
Dec 31, 2021 26.83%
Sep 30, 2021 7.48%
Jun 30, 2021 -6.49%